AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Irish pharmaceutical company enters oral drug-delivery market.
2004 JUL 14 - (NewsRx.com & NewsRx.net) -- Merrion Pharmaceuticals, Inc., has entered the $25 billion oral drug-delivery market.
The company will develop its own products and seek collaboration and licensing opportunities with pharmaceutical and biotechnology partners. Merrion was founded by Growcorp, an Irish life sciences venture capital group, to enable the acquisition of a comprehensive portfolio of drug-delivery assets from Elan Corp., plc. Michael J. McKenna, PhD, an experienced biopharmaceutical executive, has been chosen as Merrion's CEO.
Merrion has acquired a wide range of oral-delivery systems for use as enabling technologies for biotechnology products and as life cycle management tools for the pharmaceutical industry. The company's technology platforms include: penetration enhancers that improve the absorption of oral drugs through the gastrointestinal tract; gastroretentive ...
- Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral...
- Newspaper article from: Vaccine Weekly September 9, 2009 700+ words
...amp; Sullivan European Oral Drug Delivery Technology Innovation...receive the 2009 European Oral Drug Delivery Technology Innovation...leadership position in the oral drug delivery field by Frost...article was prepared by Vaccine Weekly editors from staff and...
- EURAND AWARD HONOURS ACHIEVEMENTS IN ORAL DRUG DELIVERY RESEARCH.
- News wire article from: AsiaPulse News August 10, 2007 700+ words
...research scientists in the field of applied oral drug delivery. The Awards recognized exceptional innovation in Oral Drug Delivery and exceptional contributions...the category of "Novel Approached in Oral Drug Delivery" and also selected an individual...
- Second oral drug delivery research deal signed.
- Newspaper article from: Biotech Week June 9, 2004 700+ words
...announced that it has commenced a second oral drug delivery research collaboration with...combining Access' proprietary vitamin B12 oral drug delivery technology with the collaborator's proprietary formulations to provide oral drug delivery options for these formulations...
- Drug Delivery: The Market for Oral Drug Delivery Systems Includes Top 10...
- Press release article from: M2 Presswire August 20, 2002 700+ words
...SMI: Drug Delivery: The Market for Oral Drug Delivery Systems Includes Top 10 Company...RDATE:08202002 The accelerated pace of oral drug delivery system development has been...information, and detailed market analysis for oral drug delivery systems. It will help participants...
- Oral drug shows promise as impotence treatment
- Newspaper article from: Chicago Sun-Times Howard Wolinsky July 15, 1988 700+ words
An oral drug is showing promise as an alternative...California researcher has found. The oral drug, phentolamine, which improves blood...impotent men. He decided to try the oral drug based on the success of injecting liquid...
- Drug Delivery: The Market for Oral Drug Delivery Systems; Includes top 10...
- Press release article from: M2 Presswire June 25, 2002 700+ words
...RDATE:06252002 The accelerated pace of oral drug delivery system development has been...information, and detailed market analysis for oral drug delivery systems. It will help participants...Report This report details the types of oral drug delivery systems and technologies being...
- Access Pharmaceuticals, Inc. Announces Second Oral Drug Delivery Research...
- Press release article from: PR Newswire May 13, 2004 700+ words
...announced that it has commenced a second oral drug delivery research collaboration with...combining Access' proprietary vitamin B12 oral drug delivery technology with the collaborator's proprietary formulations to provide oral drug delivery options for these formulations...
- Oral drug delivery research alliance signed.
- Newspaper article from: Biotech Week October 8, 2003 700+ words
...entered into a research collaboration in oral drug delivery with the Celltech Group plc...goal of the collaboration is to develop oral drug delivery options for Celltech's monoclonal...using Access' proprietary vitamin B12 oral drug delivery technology. In preclinical...